The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy.

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

AstraZeneca AZN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) rendered ...

Despite RFK, Jr.'s push to ban artificial food coloring dyes by 2027, Spangler Candy stands by them citing uncertain supply ...

Dr. Steven Fleischman, president of the American College of Obstetricians and Gynecologists, said: “The science has not ...

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

Many nations have stopped recommending the vaccine for children, FDA commissioner said. Critics say vaccinating pregnant ...

As of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended ...

One company that has what it takes to do that is Johnson & Johnson (NYSE: JNJ). The company recently failed to put a lid on ...

Under the terms of the clinical trial collaboration and supply agreement, Coherus will provide LOQTORZI to STORM, which will be the sponsor of the Phase 1b/2 clinical combination trial. STORM and ...

The first new antibiotic in 50 years to tackle a common superbug is entering its final phase of human testing. Swiss ...